Amgen (NASDAQ:AMGN) reported quarterly earnings of $4.96 per share which beat the analyst consensus estimate of $4.66 by 6.44 percent. This is a 5.53 percent increase over earnings of $4.70 per share from the same period last year. The company reported quarterly sales of $6.90 billion which missed the analyst consensus estimate of $6.94 billion by 0.59 percent. This is a 3.77 percent increase over sales of $6.65 billion the same period last year.